Cherry L. Wainwright

3.7k total citations
93 papers, 1.6k citations indexed

About

Cherry L. Wainwright is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Cherry L. Wainwright has authored 93 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 24 papers in Pathology and Forensic Medicine. Recurrent topics in Cherry L. Wainwright's work include Cardiac electrophysiology and arrhythmias (31 papers), Nitric Oxide and Endothelin Effects (22 papers) and Cardiac Ischemia and Reperfusion (22 papers). Cherry L. Wainwright is often cited by papers focused on Cardiac electrophysiology and arrhythmias (31 papers), Nitric Oxide and Endothelin Effects (22 papers) and Cardiac Ischemia and Reperfusion (22 papers). Cherry L. Wainwright collaborates with scholars based in United Kingdom, Hungary and Canada. Cherry L. Wainwright's co-authors include J. R. Parratt, Kathleen A. Kane, James R. Parratt, Sarah K. Walsh, Simon Kennedy, R. M. Wadsworth, Roger M. Wadsworth, Ashley M. Miller, Allan R. McPhaden and Piero A. Martorana and has published in prestigious journals such as Circulation, PLoS ONE and The FASEB Journal.

In The Last Decade

Cherry L. Wainwright

90 papers receiving 1.6k citations

Peers

Cherry L. Wainwright
Cherry L. Wainwright
Citations per year, relative to Cherry L. Wainwright Cherry L. Wainwright (= 1×) peers Akiyoshi Hara

Countries citing papers authored by Cherry L. Wainwright

Since Specialization
Citations

This map shows the geographic impact of Cherry L. Wainwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherry L. Wainwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherry L. Wainwright more than expected).

Fields of papers citing papers by Cherry L. Wainwright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cherry L. Wainwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherry L. Wainwright. The network helps show where Cherry L. Wainwright may publish in the future.

Co-authorship network of co-authors of Cherry L. Wainwright

This figure shows the co-authorship network connecting the top 25 collaborators of Cherry L. Wainwright. A scholar is included among the top collaborators of Cherry L. Wainwright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cherry L. Wainwright. Cherry L. Wainwright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wainwright, Cherry L., et al.. (2025). Short‐Term Oral Administration of the Porcupine Inhibitor, Wnt‐c59, Improves the Structural and Functional Features of Experimental HFpEF. Pharmacology Research & Perspectives. 13(1). e70054–e70054. 2 indexed citations
2.
Walsh, Sarah K., et al.. (2019). Acute dietary zinc deficiency in rats exacerbates myocardial ischaemia–reperfusion injury through depletion of glutathione. British Journal Of Nutrition. 121(9). 961–973. 8 indexed citations
3.
Walsh, Sarah K., et al.. (2019). l‐α‐Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK‐dependent pathway. Pharmacology Research & Perspectives. 7(3). e00487–e00487. 34 indexed citations
4.
Bermano, Giovanna, et al.. (2019). Seaweed-derived bioactives as potential energy regulators in obesity and type 2 diabetes. Advances in pharmacology. 87. 205–256. 26 indexed citations
5.
Wainwright, Cherry L., et al.. (2013). Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection. Proceedings of The Nutrition Society. 72(4). 460–469. 16 indexed citations
6.
Robins, Simon P., et al.. (2010). Quantitative measurement of mature collagen cross-links in human carotid artery plaques. Atherosclerosis. 211(2). 471–474. 10 indexed citations
7.
Walsh, Sarah K., Kathleen A. Kane, & Cherry L. Wainwright. (2009). Mast cells, peptides and cardioprotection – an unlikely marriage?. Autonomic and Autacoid Pharmacology. 29(3). 73–84. 10 indexed citations
8.
Markos, F., et al.. (2008). Dilatation in the femoral vascular bed does not cause retrograde relaxation of the iliac artery in the anaesthetized pig. Acta Physiologica. 194(3). 207–213. 8 indexed citations
9.
Benson, Robert A., et al.. (2007). Phospholipid chlorohydrin induces leukocyte adhesion to ApoE−/− mouse arteries via upregulation of P-selectin. Free Radical Biology and Medicine. 44(3). 452–463. 25 indexed citations
10.
Kennedy, Simon, Roger M. Wadsworth, & Cherry L. Wainwright. (2006). Locally administered antiproliferative drugs inhibit hypercontractility to serotonin in balloon-injured pig coronary artery. Vascular Pharmacology. 44(5). 363–371. 4 indexed citations
11.
Egan, Conleth A., Cherry L. Wainwright, R. M. Wadsworth, & Graeme F. Nixon. (2005). PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: Effects of altered intracellular Ca regulation. Cardiovascular Research. 67(2). 308–316. 18 indexed citations
12.
Gray, Gillian A., et al.. (2004). Sarafotoxin 6c (S6c) Reduces Infarct Size and Preserves mRNA for the ETB Receptor in the Ischemic/Reperfused Myocardium of Anesthetized Rats. Journal of Cardiovascular Pharmacology. 44(2). 148–154. 13 indexed citations
14.
Wainwright, Cherry L., Ashley M. Miller, & R. M. Wadsworth. (2001). Inflammation As A Key Event In The Development Of Neointima Following Vascular Balloon Injury. Clinical and Experimental Pharmacology and Physiology. 28(11). 891–895. 48 indexed citations
15.
Sharif, Isam, et al.. (2000). Sarafotoxin 6c Protects Against Ischaemia-Induced Cardiac Arrhythmias In Vivo and In Vitro in the Rat. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S297–S299. 13 indexed citations
16.
Garjani, Afagh, et al.. (1995). Effects of Endothelin-1 and the ETA-Receptor Antagonist, BQ123, on Ischemic Arrhythmias in Anesthetized Rats. Journal of Cardiovascular Pharmacology. 25(4). 634–642. 46 indexed citations
17.
Wainwright, Cherry L., J. R. Parratt, & Herman Van Belle. (1993). The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetized pigs. British Journal of Pharmacology. 109(2). 592–599. 26 indexed citations
18.
Wainwright, Cherry L.. (1992). Myocardial preconditioning as the heart's self-protecting response against the consequences of ischaemia. Trends in Pharmacological Sciences. 13(3). 90–93. 8 indexed citations
19.
Wainwright, Cherry L., J. R. Parratt, & Marc Bigaud. (1989). The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion. European Heart Journal. 10(3). 235–243. 32 indexed citations
20.
Wainwright, Cherry L. & James R. Parratt. (1988). Alifedrine, a positive inotropic agent that moderately reduces the severity of ischaemia and reperfusion-induced ventricular arrhythmias. European Journal of Pharmacology. 147(3). 373–380. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026